Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
- PMID: 11246620
- DOI: 10.1097/00042737-200102000-00016
Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
Abstract
Treatment of Crohn's disease with infliximab is an important drug therapy for patients with refractory and fistulating disease. There are concerns over its use in a proportion of Crohn's patients with concurrent hepatitis C infection, since there are theoretical risks of accelerated hepatic decompensation due to the immunomodulatory impact of infliximab. We report a patient with both Crohn's disease and ongoing active hepatitis C infection who underwent infliximab therapy, with no worsening of his liver function or PCR status.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
